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 Introduction
Spirometry is an important and useful tool in the diagnosis and management of 
chronic pulmonary diseases (Perez-Padilla et al., 2006). Interpretation of pulmonary 
function tests is usually based on comparisons of data measured in an individual patient 
or subject with reference (predicted) values based on healthy subjects (Pellegrino et al., 
2005). These references are used to identify abnormal values and, hence, the nature and 
degree of functional abnormality. Many different studies have established spirometric 
reference values for various populations but few studies have been conducted in Africa. 
Chronic obstructive pulmonary disease (COPD) and asthma are major health prob-
lems worldwide and the number of patients with these diseases continues to rise. It is 
predicted that by the year 2020, COPD will be the third leading cause of death and the 
fifth leading cause of disability adjusted life years worldwide (Halbert et al., 2003).
Tobacco smoking is by far the major risk factor for COPD and the prevalence of the 
disease in different countries is related to the rate of smoking and the time of introduc-
tion of cigarette smoking (Pauwels et al., 2004). The use of biomass fuel has also been 
associated with the occurrence of obstructive airways disorders (Bahera et al., 1991).
Prevalence data for asthma are lacking for many countries in Africa including Rwan-
da, but it is estimated that nearly 50 millions of Africans currently have asthma (Aît-Kha-
led et al., 2001).
 Scope and objectives of the thesis 
The overall objective of the present work was to determine the prevalence of atopy, 
asthma and COPD in Kigali, the capital of Rwanda, and in Huye district, a rural area located 
in southern Rwanda, but also to establish spirometric reference values for the Rwandan 
population.
1 This is the report of PhD research carried out at Ghent University, under the supervision of Jan Van Meerbeeck.
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Specific objectives were:
To generate predicted reference equations for the Rwandan population from  −
healthy subjects;
To measure the prevalence of risk factors of COPD and asthma including socio- −
economic status, indoor allergens, pollution (outdoor and indoor pollution), 
work exposure and smoking;
To compare the prevalence of COPD, asthma and atopy in Kigali and Huye district  −
with that reported in other developing countries;
 To determine the correlation between asthma and atopy in Kigali town and Huye  −
district.
 Patients and Methods
Between February 2008 and August 2009, a total of 2138 individuals were randomly 
recruited in the rural district of Huye and in Kigali town, localized respectively at 1568 m 
and 1768 m of altitude. In Kigali, the study was performed in Nyarugenge district, which 
is considered as the gate of the country. This district is based around the city centre of 
Kigali, it is more polluted and it contains most of the city’s businesses. With an urban 
population of 193000 subjects (Kigali city, 2012) Nyarugenge is known to be representa-
tive of the larger population of Kigali in terms of housing, socio-economic status and air 
quality. Huye district is localized in southern Rwanda and was chosen because it is less 
polluted and it is the only rural district in the country that has a University Hospital where 
spirometers could be regularly maintained. 
Inclusion criteria were age ≥ 15 years, living in Kigali town or Huye District and be-
ing competent and willing to sign the informed consent form after having been given all 
the details about the study.
Exclusion criteria for the study were age below 15 years or having any mental illness, 
recent myocardial infarction or history of admission for cardiac illness within the last 5 
months, recent thoracic, abdominal or eye surgery (or retinal detachment) and pregnant 
women. Subjects with active tuberculosis or any acute lung infections were also exclud-
ed. Only those who signed the informed consent form participated in the study. These 
filters left us with 1824 participants for the study on the prevalence of atopy, asthma and 
COPD in Rwanda.
For producing spirometric reference values, only healthy subjects were included, 
participants who reported respiratory symptoms such as dyspnoea, chronic cough, 
phlegm or wheeze, those known to be asthmatic or suffering from chronic bronchitis, 
COPD and emphysema, active smokers and ex-smokers, subjects with obesity (Body mass 
index (BMI) >30 kg/m2) were all excluded. In total 740 healthy subjects were included for 
generating spirometric reference values for the Rwandan population.
After height and weight were measured, a questionnaire on respiratory symptoms 
and history of respiratory diseases, smoking history, exposure to various chemical agents 
and dust was administrated to each participant. For smoking history, non-smokers were 
defined as those who never had smoked; smokers were those who were currently smo-
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king at least one cigarette per day, and ex-smokers those who reported having smoked on 
a regular basis until ≥ 5 months before the examination. Passive smokers were defined 
as subjects who were regularly (daily basis) exposed to environmental tobacco smoke 
at least during the last 12 months. The questionnaires used were a short version of the 
American Thoracic Society (ATS-DLD, 1978) and the European Community Respiratory 
Health Survey II questionnaires (ECRHS II, 2002).
Spirometry was performed using a ML 3535 microloop spirometer with a database 
storage capacity for over 1000 patients (Microloop 3535, SPIDA spirometry, Micromedi-
cal limited, UK). The spirometric parameters used were: FEV1 (Forced Expiratory Volume 
in one second), FVC (Forced Vital Capacity), FEV1 /FVC ratio and PEF (Peak Expiratory 
Flow). 
After explanation of the procedures and demonstration by the technician, using lo-
cal language, participants were asked to perform up to 8 maneuvers to obtain 3 accept-
able flow-volume curves. The spirometry with largest value of FVC and FEV was consid-
ered as the best and used for analysis. Equipments and procedures were in accordance 
with the American Thoracic Society for spirometry (American Thoracic Society, 1995). 
Spirometers were daily calibrated using a 3 liter’s syringe.
All the patients were skin prick tested for six common allergen extracts (Laboratoire 
Stallergène, Waterloo, Belgium): house dust mite, grass pollen mix, cat dander, dog dan-
der, aspergillus and cockroach plus a negative and positive control (Histamine).
 Ethical considerations
Ethical approval was obtained from both the Ghent University Hospital Ethics Com-
mittee (Belgium) and the Rwanda National Ethics Committee. Only subjects who signed 
the informed consent form participated in the study.
 Statistical methods
Statistical analyses were performed using the statistical package SPSS 12.01 and sta-
tistical significance was viewed as P values lower than 0.05. Odds ratios (OR) and 95% 
confidence intervals (CI) were calculated, the data of height, age and lung function pa-
rameters were expressed as means ± SD (Standard deviation). Ratio FEV1/FVC was ex-
pressed as a percentage. A logistic regression model was performed using age, gender, 
smoking, residential area as independent variables and obstructive lung diseases as de-
pendant variables.
 Results
65.2% of participants were below age 45 years and 34.8% above 45 years; this re-
flects the Rwandan general population distribution where more than 60% of the popula-
tion is under 40 years and where women are overrepresented (Table 1).
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Variables Kigali Huye N
Gender
Men 502 376 878 (48.1%)
Women 534 412 946 (51.9%)
Age (years)
15-29 396 308 704 (38.6%)
Male 200 158 358 (40.7%)
Female 196 150 346 (36.5%)
30-44 286 199 485 (26.6%)
Male 134 96 230 (26.2%)
Female 152 103 255 (27.0%)
45-60 249 212 461 (25.3%)
Male 120 96 216 (24.6%)
Female 129 116 245 (25.9%)
>60 105 69 174 (9.6%)
Male 41 33 74 (8.5%)
Female 66 34 100 (10.6%)
Marital status 
Never married 420 378 798 (43.8%)
Married 348 336 684 (37.5%)
Divorced/separated 46 50 96 (5.3%)
Widowed 134 112 246 (13.5%)
Level of education
None 284 204 488 (26.7%)
Primary school 398 314 712 (39%)
Secondary school 290 151 441 (24.1%)
More than secondary school 112 71 183 (10%)
Body Mass Index (Kg/m2)
<18.5 42 66 108 (5.9%)
18.5-24.9 640 596 1236 (67.7%)
25-29.9 201 111 312 (17.1%)
>30 76 32 108 (5.9%)
Table 1. Description of the sample according to socio-demographic variables and anthropometric measures
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Of the 1824 subjects who performed spirometry, 256 (14%) were classified as having 
airflow obstruction with a ratio FEV1/FVC< LLN. All participants with airflow limitation 
underwent a post bronchodilator spirometry, among them, 174 out of 256 subjects (94 
females and 80 males) had a significant improvement of FEV1 which was greater or equal 
to 12% predicted and 200 ml. 
Asthma was diagnosed in 163 (8.9%) individuals (table 2). Eleven subjects who 
had a good reversibility after administration of a bronchodilator were not considered 
as asthmatics since they reported a history of tuberculosis and mentioned that asthma-
like symptoms started after tuberculosis treatment. With regard to doctor’s diagnosis of 
asthma, 121 (74.2%) out of 163 individuals who met our criteria for asthma had a doctor’s 
diagnosis of asthma.
Total Age group Men Women P-value
Atopy 290 < 45 137 153 NS
194 ≥ 45 91 103 NS
Asthma 113 < 45 54 59 NS
50 ≥ 45 22 28 NS
COPD 22 < 45 10 12 NS
60 ≥ 45 50 10 <0.001
Table 2. Prevalence of atopy, asthma and COPD
COPD was diagnosed in 82 (4.5%) subjects who presented a ratio FEV1/FVC less than 
the LLN and was more frequently diagnosed in men than in women; the difference was 
statistically significant. The prevalence of COPD was higher among current (11.2%) and 
ex-smokers (8.6%) compared to non-smokers (1.9%). 59 (71.9%) subjects with COPD were 
current smokers or ex-smokers and about one third (28%) were non-smokers. Among 635 
individuals aged 45 years and above, COPD was diagnoses in 9.6% of the subjects. 484 par-
ticipants (26.5%) had a positive skin prick test meaning a wheal at least 3mm greater than 
the negative control. House dust mites and grass pollen were the main allergens found with 
respectively 10.7% (13.2% in Kigali versus 7.6% in Huye) and 7.2% (5.8% in Kigali versus 
9.1% in Huye) sensitized participants.
Logarithmic prediction equations formula derived from men and women with 
age and height as independent variables are shown in table 3. Prediction equations for 
the means were obtained by regressing the natural logarithms of each lung parameter 
against ln(height) and square age.
Sex Equations R2 RSD
Females
FVC Exp (-10.116 + 2.2238 ln(H) - 0.000071A2) 0.482 0.11
FEV1 Exp (-8.614 + 1.905 ln(H) - 0.0000821A2) 0.471 0.11
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Sex Equations R2 RSD
FEV1/FVC Exp (5.848– 0.268 ln(H) – 0.000839 A) 0.621 0.08
PEF Exp (-5.631 + 1.416 ln(H) + 0.00086A2) 0.082 0.17
Males
FVC Exp (-12.528 + 2.724 ln(H) – 0.0000564A2) 0.516 0.12
FEV1 Exp (-10.668 + 2.334 ln(H) – 0.0000652A2) 0.447 0.12
FEV1/FVC Exp (7.1477 – 0.518 ln(H) – 0.001025A) 0.073 0.06
PEF Exp (6.142 + 1.612 ln(H) – 0.000216A2) 0.151 0.24
Table 3. Prediction equations for male and female between 15 and 80 years old (n=740)
(A: age in years, H: Height in centimeters, R2: fraction of explained variance, RSD: Residual standard deviation, Exp(x)= ex)
When we compared our spirometric reference values with studies done in white 
populations, values for FEV1 and FVC in the current study were lower than those derived 
from Caucasians at the same age and height. With men, our results for FEV1 were 9 to 
12% lower and FVC was 16 to 18% lower than those from selected studies done with white 
subjects. With women, FEV1 was 12 to 23% lower and FVC from 17 to 28% lower. Com-
parison with African-Americans and black Africans did not show significant differences 
in the pulmonary function testing values and they were nearly similar to those for black 
Americans by Hankinson.
 Discussion
In developing countries, chronic respiratory diseases represent a challenge to public 
health because of their frequency, severity, projected trends and economic impact (Ehr-
lich et al., 2005). The aim of this research was to generate spirometric reference values 
and to determine the prevalence of asthma, atopy and COPD in Rwanda using question-
naires, spirometry and allergy skin-prick tests. The overall prevalence of COPD was 4.5% 
and all participants with COPD had a history of smoking. The WHO has published data 
placing the worldwide prevalence of COPD at 0.8% and Africa having probably the lowest 
prevalence in the world (Pauwels RA et al. 2004: 613-620). The low prevalence of COPD 
in Africa is thought to be a reflection of Africa’s young population, with 44% under 15 
years and only 3.2% over 65 years, and because of the low prevalence of smoking (Behera 
et al., 1991).
Our prevalence is close to other studies which place the prevalence of COPD sub-
stantially higher, at approximately 4 to 6%. The conflicts among published COPD preva-
lence rates may be due to many factors, including true differences in disease occurrence, 
differences in defining obstructive lung disease, cultural biases, and whether spirometry 
was used to confirm the diagnosis (Halbert et al., 2003). This study revealed a prevalence 
of asthma of 8.9% in Kigali town and Huye district and a significant association to atopy. 
26.5% of participants had a positive skin-prick test to at least one allergen. Furthermore, 
the fact of living in Kigali, the capital, was an important risk factor for having asthma. 
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Although statistically significant, the difference in asthma prevalence between Huye Dis-
trict and Kigali town was not too large; the magnitude of the urban-rural differences has 
lessened over recent years due to the relatively greater increase in asthma prevalence in 
rural communities as they increasingly adopt Western lifestyles (Odhiambo et al., 1998). 
In developing regions, asthma prevalence continues to rise sharply with increases 
in urbanization and westernization (Braman, 2006). The rising prevalence of asthma has 
been ascribed to a number of factors including a reduction in the prevalence of childhood 
infections, change in diet and lifestyle, economic development, and increased exposure 
to various pollutants.
 Conclusion
This is the first study which shows the prevalence of atopy, asthma and COPD in 
Rwanda. Asthma and COPD were respectively diagnosed in 8.9% and 4.5% of the par-
ticipants. COPD was diagnosed in 9.6% of the subjects aged ≥ 45 years and was higher 
among current smokers (11.2%). Spirometric reference values in our study were nearly 
similar to those for black Americans by Hankinson. Considering the similarities of the 
Great Lake regions inhabitants, the reference equations obtained in Rwanda population 
can be used in neighbouring countries while waiting for further studies in the region.
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